ENG/中
美国
老虎證券
行情
产品介绍
Cash Boost账户
美股
美股碎股
港股
A股通
期权
期货
美国国债
定投
固定票息票据
Tiger BOSS Debit Card
基金超市
老虎钱袋子
老虎API平台
Wealth
费用
综合账户
股票与ETF
期权、窝轮与牛熊证
期货
债券
基金超市
Cash Boost
股票与ETF
融资利率
活动
帮助
账户操作
如何开户
开户文件
账户类型
资金与转仓
入金
DDA快捷入金
出金
转入股票
转出股票
货币兑换
产品与交易
可交易产品
订单类型
交易规则
申报
融资融券
保证金与杠杆
风险管理
做空风险
基金超市
基金开户与交易
Cash Boost账户
Cash Boost 账户FAQ
如何开通 Cash Boost 账户
如何用Cash Boost 账户交易
如何绑定CDP证券账户
Tiger Boss Debit Card
常见问题
费用说明
如何充值
如何使用我的Debit card
账单报表
账单报表
股息(分红)
专栏
TigerAI
机构
财富及资产管理人
自营交易机构
介绍经纪商
三方服务商
登入
立即註冊
Toggle
美股
詳情
本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務
Maze Therapeutics
9.71
+0.5750
6.30%
成交量:
12.15萬
成交額:
117.56萬
市值:
4.25億
市盈率:
7.76
高:
10.24
開:
9.50
低:
9.07
收:
9.13
資料載入中...
總覽
公司
新聞
公告
公司資料
公司名字:
Maze Therapeutics
交易所:
NASDAQ
成立時間:
2017
員工人數:
125
公司地址:
171 Oyster Point Blvd,Suite 300,South San Francisco,California,United States
官網:
http://www.mazetx.com
郵編:
94080
電話:
650 850 5070
傳真:
- -
簡介:
Maze Therapeutics, Inc.於2017年8月29日根據特拉華州法律成立。該公司是一家臨床階段的生物製藥公司,利用人類遺傳學的力量,為患有腎臟、心血管和相關代謝或CVRM疾病,包括肥胖症的患者開發新穎的小分子精準藥物。該公司正在推進使用他們的Compass平台的管道,這使他們能夠識別和表徵疾病中的遺傳變異,然後通過該公司稱為變異功能化的過程將這些變異與驅動特定患者群體疾病的生物途徑聯繫起來。他們的羅盤平台專為通過臨床試驗設計告知藥物發現和開發過程的所有階段而構建。該公司目前正在推進兩個全資主導項目,MZE829和MZE782,每一個項目都代表了一種新的基於精準醫學的慢性腎病(CKD)方法。
董事
名稱
職位
Charles Homcy
Chairman of the Board, Director
Jason Coloma
Chief Executive Officer and Director
Catherine Angell Sohn
Director
Daniel Spiegelman
Director
Jonathan Lim
Director
Nancy C. Andrews
Director
Neil Exter
Director
Richard Scheller
Director
Sekar Kathiresan
Director
股東
名稱
職位
Jason Coloma
Chief Executive Officer and Director
Atul Dandekar
Chief Strategy and Business Officer
Courtney Phillips
General Counsel and Corporate Secretary
Harold S. Bernstein
President, Research and Development and Chief Medical Officer
{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股,新股,港股,A股等全球金融理财产品。新加坡华人最信赖的在线投资平台,现在加入即享低费用,24/5 无时差炒美股投资理财!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/MAZE/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"MAZE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAZE\",,,,,undefined,":{"symbol":"MAZE","market":"US","secType":"STK","nameCN":"Maze Therapeutics","latestPrice":9.705,"timestamp":1745345280309,"preClose":9.13,"halted":0,"volume":121501,"delay":0,"floatShares":18431500,"shares":43796057,"eps":1.25,"marketStatus":"交易中","change":0.575,"latestTime":"04-22 14:08:12 EDT","open":9.5,"high":10.24,"low":9.07,"amount":1175567.251871,"amplitude":0.128149,"askPrice":9.74,"askSize":281,"bidPrice":9.65,"bidSize":97,"shortable":3,"etf":0,"ttmEps":1.25,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1745352000000},"marketStatusCode":2,"adr":0,"listingDate":1738299600000,"exchange":"NASDAQ","adjPreClose":9.13,"preHourTrading":{"tag":"盘前","latestPrice":8.95,"preClose":9.13,"latestTime":"09:16 EDT","volume":308,"amount":2733.8600520000005,"timestamp":1745327819822},"postHourTrading":{"tag":"盘后","latestPrice":9.13,"preClose":9.13,"latestTime":"16:05 EDT","volume":246,"amount":2245.98,"timestamp":1745265907837},"volumeRatio":1.35306},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"MAZE\",,,,,undefined,":{"symbol":"MAZE","floatShares":18431500,"roa":"23.07%","roe":"50.47%","lyrEps":1.421062,"volumeRatio":1.35306,"shares":43796057,"dividePrice":0,"high":10.24,"amplitude":0.128149,"preClose":9.13,"low":9.07,"week52Low":6.71,"pbRate":"-1.37","psRate":"2.54","week52High":17,"institutionHeld":0,"latestPrice":9.705,"committee":-0.486772,"eps":1.25,"divideRate":0,"volume":121501,"delay":0,"ttmEps":1.25,"open":9.5,"prevYearClose":16,"prevWeekClose":8.41,"prevMonthClose":11.01,"prevQuarterClose":11.01,"fiveDayClose":8.5,"twentyDayClose":11.86,"sixtyDayClose":16},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":602685968,"yearFounded":2017,"employeeNum":125,"address":"171 Oyster Point Blvd,Suite 300,South San Francisco,California,United States","zipCode":"94080","officePhone":"650 850 5070"},"stockCompanyDetail":{"websiteUrl":"http://www.mazetx.com","stockEarnings":[{"period":"1week","weight":0.0741},{"period":"1month","weight":-0.1804},{"period":"3month","weight":-0.4294},{"period":"ytd","weight":-0.4294}],"compareEarnings":[{"period":"1week","weight":-0.0468},{"period":"1month","weight":-0.0888},{"period":"3month","weight":-0.1479},{"period":"6month","weight":-0.1109},{"period":"1year","weight":0.0378},{"period":"ytd","weight":-0.1232}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"Maze Therapeutics, Inc.於2017年8月29日根據特拉華州法律成立。該公司是一家臨床階段的生物製藥公司,利用人類遺傳學的力量,為患有腎臟、心血管和相關代謝或CVRM疾病,包括肥胖症的患者開發新穎的小分子精準藥物。該公司正在推進使用他們的Compass平台的管道,這使他們能夠識別和表徵疾病中的遺傳變異,然後通過該公司稱為變異功能化的過程將這些變異與驅動特定患者群體疾病的生物途徑聯繫起來。他們的羅盤平台專為通過臨床試驗設計告知藥物發現和開發過程的所有階段而構建。該公司目前正在推進兩個全資主導項目,MZE829和MZE782,每一個項目都代表了一種新的基於精準醫學的慢性腎病(CKD)方法。","exchange":"NASDAQ","name":"Maze Therapeutics","nameEN":"Maze Therapeutics"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"MAZE\",market:\"US\",,,undefined,":{"directors":[{"name":"Charles Homcy","position":"Chairman of the Board, Director"},{"name":"Jason Coloma","position":"Chief Executive Officer and Director"},{"name":"Catherine Angell Sohn","position":"Director"},{"name":"Daniel Spiegelman","position":"Director"},{"name":"Jonathan Lim","position":"Director"},{"name":"Nancy C. Andrews","position":"Director"},{"name":"Neil Exter","position":"Director"},{"name":"Richard Scheller","position":"Director"},{"name":"Sekar Kathiresan","position":"Director"}],"executives":[{"name":"Jason Coloma","position":"Chief Executive Officer and Director"},{"name":"Atul Dandekar","position":"Chief Strategy and Business Officer"},{"name":"Courtney Phillips","position":"General Counsel and Corporate Secretary"},{"name":"Harold S. Bernstein","position":"President, Research and Development and Chief Medical Officer"}]},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/MAZE\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"MAZE","fiscalQuarterEnding":"2024/12","expectedEps":-7.6,"name":null,"time":"","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"","actualEps":-18.32}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"MAZE\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"MAZE\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.5,"buy":0.5,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.5,"analysts":4,"updateTime":1740715200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/MAZE\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"MAZE","date":"2025-04-21","current":7.051844,"percent":0.109091,"low":6.347498,"twenty":8.301219,"median":9.285161,"eighty":9.954897,"high":12.681398,"avg":9.125523,"sd":1.419875,"marketCap":368324839},"quantilePoints":[{"date":"2025-01-31","current":12.681398,"twenty":12.46124,"median":12.543799,"eighty":12.626358,"marketCap":700431648},{"date":"2025-02-07","current":10.303636,"twenty":10.343265,"median":11.88881,"eighty":12.594654,"marketCap":569100714},{"date":"2025-02-14","current":8.972089,"twenty":9.94063,"median":10.40271,"eighty":12.302722,"marketCap":495555390},{"date":"2025-02-21","current":9.645788,"twenty":9.645788,"median":10.220414,"eighty":11.88881,"marketCap":532765822},{"date":"2025-02-28","current":10.081711,"twenty":9.495197,"median":10.081711,"eighty":10.604819,"marketCap":556843160},{"date":"2025-03-07","current":9.29705,"twenty":9.29705,"median":9.788453,"eighty":10.501783,"marketCap":513503951},{"date":"2025-03-14","current":8.956237,"twenty":8.972089,"median":9.582381,"eighty":10.303636,"marketCap":494679851},{"date":"2025-03-21","current":9.479345,"twenty":8.972089,"median":9.534826,"eighty":10.271932,"marketCap":523572656},{"date":"2025-03-28","current":8.93246,"twenty":8.956237,"median":9.495197,"eighty":10.168896,"marketCap":493366542},{"date":"2025-04-04","current":7.814885,"twenty":8.89283,"median":9.443679,"eighty":10.137192,"marketCap":408179251},{"date":"2025-04-11","current":6.372653,"twenty":8.695317,"median":9.384234,"eighty":10.081711,"marketCap":332850033},{"date":"2025-04-17","current":6.858987,"twenty":8.362362,"median":9.29705,"eighty":9.98026,"marketCap":358251746},{"date":"2025-04-21","current":7.051844,"twenty":8.301219,"median":9.285161,"eighty":9.954897,"marketCap":368324839}],"updateTime":1745345292593}}}